SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Good Investment Ideas By People You Trust
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

6 pts

Opinion on  SanofiAventis (SNY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
SNY is a buy

Jun 22, 2007 05:52 PM UTC
Return Risk
-48.76% LOW
Analyst

If SNY's cash flow just continues "as is" this company is worth almost twice the current price of about $40.

Hammered by the Accomplia news but is it really bad enough news to keep this company from continuing its current cash flow? No, SNY will be putting all that cash flow to work and growing.

The current price is about 10% cheaper than where Buffett last bought in (but before the Accomplia news)

What's the downside? I can't think there is much room to go down. if there is, I'm buying more.


SNY:  This call was made on 06/22/07 @ $40.45
Rating:   Positive   $40.45 (06/22/07)
Gain/Loss:   -21.38% in 567 days
Target:   $47.00 (+16.19%) in > one year


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 Gerald Greene 17.80 +39.28% 79
2 krprasad 15.63 +15.75% 10
3 akiralegrand 14.33 +16.71% 41
4 stockmarketfunding.com 14.22 +22.85% 16
5 noshoes 13.47 +29.97% 183


POPULAR STOCKS
Symbol Company Name Sentiment
AMD Advanced Micro Devices Inc
GM General Motors Corp
MSFT Microsoft Corp
T AT&T Inc
WM Washington Mutual Inc
AIG American International Group Inc.

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
SanofiAventis (SNY)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
84.5%
Top:
100.0%




Latest Picks by colindelia
Symbol SP Sentiment Rating Return Since
KG Positive -41.70% 07/30/07
XEC Positive -30.64% 07/12/07
TCK Positive -85.89% 07/03/07
CRYP Positive -87.64% 07/02/07
PFE Positive -30.65% 06/22/07

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch